Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Sep;188(9):2772-2776.
doi: 10.1002/ajmg.a.62766. Epub 2022 May 2.

MYH7 variants cause complex congenital heart disease

Affiliations
Case Reports

MYH7 variants cause complex congenital heart disease

Alyssa Ritter et al. Am J Med Genet A. 2022 Sep.

Abstract

MYH7, encoding the myosin heavy chain sarcomeric β-myosin heavy chain, is a common cause of both hypertrophic and dilated cardiomyopathy. Additionally, families with left ventricular noncompaction cardiomyopathy (LVNC) and congenital heart disease (CHD), typically septal defects or Ebstein anomaly, have been identified to have heterozygous pathogenic variants in MHY7. One previous case of single ventricle CHD with heart failure due to a MYH7 variant has been identified. Herein, we present a single center's experience of complex CHD due to MYH7 variants. Three probands with a history of CHD, LVNC, and/or arrhythmias were identified to have MYH7 variants through multigene panel testing or exome sequencing. These three patients collectively had 12 affected family members, four with a history of Ebstein anomaly and seven with a history of LVNC. These findings suggest a wider phenotypic spectrum in MYH7-related CHD than previously understood. Further investigation into the possible role of MYH7 in CHD and mechanism of disease is necessary to fully delineate the phenotypic spectrum of MYH7-related cardiac disease. MYH7 should be considered for families with multiple individuals with complex CHD in the setting of a family history of LVNC or arrhythmias.

Keywords: MYH7; cardiomyopathy; congenital heart disease; heart failure; myosin; noncompaction.

PubMed Disclaimer

References

REFERENCES

    1. Bettinelli, A. L., Mulder, T. J., Funke, B. H., Lafferty, K. A., Longo, S. A., & Niyazov, D. M. (2013). Familial ebstein anomaly, left ventricular hypertrabeculation, and ventricular septal defect associated with a MYH7 mutation. American Journal of Medical Genetics. Part A, 161A(12), 3187-3190.
    1. Clarke, N. F., Amburgey, K., Teener, J., Camelo-Piragua, S., Kesari, A., Punetha, J., Waddell, L. B., Davis, M., Laing, N. G., Monnier, N., North, K. N., Hoffman, E. P., & Dowling, J. J. (2013). A novel mutation expands the genetic and clinical spectrum of MYH7-related myopathies. Neuromuscular Disorders, 23(5), 432-436.
    1. Dellefave, L. M., Pytel, P., Mewborn, S., Mora, B., Guris, D. L., Fedson, S., Waggoner, D., Moskowitz, I., & McNally, E. M. (2009). Sarcomere mutations in cardiomyopathy with left ventricular hypertrabeculation. Circulation. Cardiovascular Genetics, 2(5), 442-449.
    1. Gibson, K. M., Nesbitt, A., Cao, K., Yu, Z., Denenberg, E., DeChene, E., Guan, Q., Bhoj, E., Zhou, X., Zhang, B., Wu, C., Dubbs, H., Wilkens, A., Medne, L., Bedoukian, E., White, P. S., Pennington, J., Luo, M., Conlin, L., … Santani, A. (2018). Novel findings with reassessment of exome data: Implications for validation testing and interpretation of genomic data. Genetics in Medicine, 20(3), 329-336.
    1. Hinton, R. B., Michelfelder, E. C., Marino, B. S., Bove, K. E., & Ware, S. M. (2010). A fetus with hypertrophic cardiomyopathy, restrictive, and single-ventricle physiology, and a beta-myosin heavy chain mutation. The Journal of Pediatrics, 157(1), 164-166.

Publication types

MeSH terms

LinkOut - more resources